Opcjonalna analityka produktu
Za zgodą użytkownika stosujemy ograniczoną analitykę chroniącą prywatność, aby zrozumieć, które ścieżki badawcze działają. Nie używamy trackerów reklamowych ani nagrywania sesji. Ten wybór można zmienić w Preferencjach. Przeczytaj Politykę prywatności.
Zions Bancorporation, National Association's published Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $9.0B | |
|---|---|---|
| Revenue (ttm) | 3.8B | |
| Net income (ttm) | 1.2B | |
| EPS (ttm) | $8.15 | |
| Shares out | 144.9M | |
| P/E (trailing) | 8.0x | |
| P/E (forward) | 9.2x | |
| Dividend | $1.92 (2.94%) | |
| Volume | 1,196,117 | |
| Beta | 0.83 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $449.0M | $495.0M | $503.0M | $513.0M | $529.0M | +4.2% |
| Gross profit | $3.19B | $3.03B | $2.98B | $3.06B | $3.32B | +1.0% |
| Operating income | $1.45B | $1.15B | $886.0M | $1.01B | $1.18B | -5.1% |
| Net income | $1.13B | $907.0M | $680.0M | $784.0M | $899.0M | -5.5% |
| EPS (diluted) | $6.79 | $5.79 | $4.35 | $4.95 | $6.01 | -3.0% |
| EBITDA | $1.43B | $1.26B | $1.03B | $1.14B | $1.29B | -2.6% |
| R&D | — | — | — | — | — | — |
| SG&A | $1.16B | $1.29B | $1.35B | $1.37B | $1.52B | +6.9% |
Recent company headlines from major financial publishers.
The constructive path carries a 20.0% probability and projects a target value of $119.01, representing an implied return of 92.6% above $61.78. In this outcome, sustained monetary tightening accelerates variable-rate loan yields, robust economic activity across Western markets drives strong middle-market credit demand, and technological efficiencies widen operating margins.
Our modal path carries a 55.0% probability and indicates a target value of $73.60, delivering an implied return of 19.1% from the analysis price of $61.78. This path is supported by upper single-digit net interest income growth as commercial loans reprice, positive operating leverage of one hundred to one hundred fifty basis points, and manageable credit provisions across Western regional franchises.
| Ke ↓ / g → | 2.0% | 2.3% | 2.5% | 2.8% | 3.0% |
|---|---|---|---|---|---|
| 7.2% | $80.2 | $82.3 | $84.8 | $87.5 | $90.5 |
| 7.7% | $75.0 | $76.7 | $78.7 | $80.9 | $83.2 |
| 8.2% | $70.5 | $72.0 | $73.6 | $75.4 | $77.3 |
| 8.7% | $66.7 | $67.9 | $69.2 | $70.7 | $72.3 |
| 9.2% | $63.3 | $64.3 | $65.5 | $66.7 | $68.0 |
Upcoming earnings date and setup when available.
Rekomendacja, którą nosiło opublikowane w danym miesiącu wydanie analizy. Rekomendacja porównuje cenę z dnia analizy z wartością godziwą; nie jest zapisem tego, czy ocena się sprawdziła.
| Rok | sty | lut | mar | kwi | maj | cze | lip | sie | wrz | paź | lis | gru |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
